U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958016) titled 'Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.' on April 23.
Brief Summary: The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.
Study Start Date: Jan. 12, 2024
Study Type: OBSERVATIONAL
Condition:
Chronic Coronary Syndrome
Recruitment Status: RECRUITING
Sponsor: University of Thessaly
Information provided by (Responsible Party): Fotios Skoufis, University of Thessaly
Published by HT D...